Old Web
English
Sign In
Acemap
>
authorDetail
>
Cheri E. Klein
Cheri E. Klein
AbbVie
Medicine
Endocrinology
Internal medicine
Dosing
Hormone
3
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetic and Pharmacodynamic Profiles of Ethinylestradiol/Norgestimate Combination or Norethindrone upon Coadministration with Elagolix 150 mg Once Daily in Healthy Premenopausal Women.
2021
Clinical Pharmacokinectics
Robert A. Feldman
Yi Lin Chiu
Cheri E. Klein
Juki Ng
Show All
Source
Cite
Save
Citations (0)
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
2019
Clinical Pharmacokinectics
Mohamad Shebley
Akshanth R. Polepally
Ahmed Nader
Juki Ng
Insa Winzenborg
Cheri E. Klein
Peter A. Noertersheuser
Megan A. Gibbs
Nael M. Mostafa
Show All
Source
Cite
Save
Citations (18)
Elagolix suppresses ovulation in a dose-dependent manner: Results from a 3-month, randomized study in ovulatory women.
2019
The Journal of Clinical Endocrinology and Metabolism
David F. Archer
Juki Ng
Kristof Chwalisz
Yi Lin Chiu
Eve C. Feinberg
Charles E. Miller
Robert A. Feldman
Cheri E. Klein
Show All
Source
Cite
Save
Citations (10)
1